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Purpose: To evaluate the diagnostic performance of velocity- and acceleration-sensitized non-
contrast enhanced magnetic resonance angiography (NCE-MRA) of the infrageniculate arteries using 
contrast-enhanced MRA (CE-MRA) as a reference standard. 
Materials & Methods: 24 patients with symptoms of peripheral arterial disease were recruited. Each 
patient’s infrageniculate arterial tree was examined using a velocity-dependent flow-sensitized 
dephasing (VEL-FSD) technique, an acceleration-dependent (ACC-FSD) technique and our 
conventional CE-MRA technique performed at 1.5T. The images were independently reviewed by 2 
experienced vascular radiologists, who evaluated each vessel segment to assess visibility, diagnostic 
confidence, venous contamination and detection of pathology. 
Results: 432 segments were evaluated by each of the 3 techniques by each reader in total. Overall 
diagnostic confidence was rated as moderate or high in 98.5% of segments with CE-MRA, 92.1% with 
VEL-FSD and 79.9% with ACC-FSD. No venous contamination was seen in 96% of segments with CE-
MRA, 72.2% with VEL-FSD and 85.8% with ACC-FSD. Per-segment, per-limb and per-patient 
sensitivities for detecting significant stenotic disease were 63.4%, 73% and 92% respectively for ACC-
FSD, and 65.3%, 87.2% and 96% for VEL-FSD, and as such no significant statistical change was 
detected using McNemars chi squared test with p-values of 1.00, 0.13 and 0.77 obtained 
respectively.  
Conclusions: Flow-dependent NCE-MRA techniques may have a role to play in evaluation of patients 
with peripheral vascular disease. Increased sensitivity of a velocity-based technique compared to an 
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Peripheral Arterial Disease (PAD) is a condition with increasing prevalence in the western world 
which has a significant impact on individual patients in terms of morbidity and mortality and on the 
wider health community as a whole [1].  Treatment options include lifestyle and medical measures 
along with surgical and increasingly endovascular procedures. Diagnostic imaging plays an important 
role in directing management with Duplex Ultrasound (DUS), CT Angiography (CTA) and Contrast 
Enhanced –Magnetic Resonance Angiography (CE-MRA) all being well established techniques [2]. 
These imaging modalities each have their  own strengths and weaknesses. DUS has the advantage of 
being inexpensive, and being readily available. However its effectiveness is reduced in obese 
patients and in the assessment of the supra-inguinal arteries, particularly in the presence of bowel 
gas. In addition, operator dependency remains an important limitation in its utility.  CTA provides an 
excellent overview of the vascular system, however it employs ionising radiation and the relatively 
high prevalence of renal impairment [3] in this cohort of often elderly arteriopaths means the use of 
intravascular contrast medium is often contra-indicated. In addition, accurate assessment of the 
small vessels below the knee, which are often heavily calcified, may prove challenging with CTA [4]. 
CE-MRA avoids the limitations of reduced effectiveness in the supra-inguinal region and the use of 
ionizing radiation. However, the use of gadolinium-based agents in CE-MRA has been implicated in 
the development of Nephrogenic Systemic Fibrosis (NSF) for patients with impaired renal function 
[5]. More recently, concerns have been raised regarding the accumulation of excess Gadolinium 
within the brain [6].  
Given the limitations of each of the conventionally employed imaging modalities, it is no surprise 
that in recent years attention has turned to the development of Non-Contrast-Enhanced Magnetic 
Resonance Angiography (NCE-MRA) for evaluation of the peripheral vasculature. In addition to 
negating concerns regarding NSF, NCE-MRA also avoids the issue of resolution limitations during first 
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pass acquisition. Additionally, it does not require careful timing of the acquisition relative to a bolus 
passage, and can bring increased flexibility, for example allowing repeated acquisitions. Over time, 
original non-contrast techniques such as time of flight imaging have fallen out of favor for body 
imaging due to longer imaging times and concerns regarding image quality [7]. A number of newer 
techniques have been described which rely on intrinsic properties of flowing blood, such as 
relaxation times or flow characteristics [8-13].  It is important that such methods are evaluated 
against existing techniques as a standard, with promising results already seen using a number of 
different techniques [14-16]. 
One recently developed NCE-MRA method uses a subtraction-based technique, combined with a 
controllable flow-dependent preparation module which suppresses the signal from flowing blood 
[13,17]. A “dark blood” image is produced which can be subtracted from a non-flow-suppressed 
“bright blood” image to produce an image of the vasculature. By adjusting the strength of the 
motion sensitization gradients (MSG), the flow suppression can be adjusted such that visualisation of 
the arteries, veins or both is optimised. This technique is known either as ‘Flow-Sensitized 
Dephasing’ (FSD) or as ‘Vascular Anatomy by Non-Enhanced Static Subtraction Angiography’ 
(VANESSA), and has previously been used to visualise the infrageniculate vessels [18].  More 
recently, it has been demonstrated in healthy volunteers that the use of an acceleration-dependent 
flow-suppression module (then referred to as ‘ADVANCE-MRA’) rather than a velocity-dependent 
flow-suppression module can improve arterio-venous separation, due to the intrinsic pulsatility of 
arterial flow [19]. The objective of this study was to compare the diagnostic  and qualitative 
performance of the acceleration- and velocity-sensitized techniques in a population of patients with 
peripheral arterial disease, using our standard CE-MRA technique (Time-resolved imaging of contrast 
kinetics – TRICKS) as a reference standard. In this work, the velocity-sensitized FSD method will be 




Materials and methods 
 
The study was approved by the local ethical committee and written informed consent was obtained 
from all patients. 24 patients with symptoms of peripheral arterial disease were recruited following 
referral for routine contrast enhanced MRA. 
Pulse sequences and scan protocols 
The MRI examinations were performed using a 1.5 T MR system (Signa HDx, GE Healthcare, 
Waukesha, WI) with an 8-channel cardiac array coil. The 2 non-contrast methods under investigation 
were performed initially, followed by the routine CE-MRA. Scan triggering was performed using 
pulse oximetry. In order to locate the major leg arteries, an initial axial multi-slice 2D time of flight 
(TOF) acquisition was acquired, with the following scan parameters: echo time (TE) 1.4 ms; 
repetition time (TR) 4.9 ms; flip angle 60; acquired matrix 256×96; field of view (FoV) 33×25cm2; 
slice thickness 5 mm; 84 slices. This was followed by a single-slice axial 2D cine phase-contrast 
acquisition through the popliteal arteries below the knee (TE 3.7 ms; TR 7.1 ms; flip angle 30; 
acquired matrix 256×64; field of view (FoV) 28×14 cm2; slice thickness 5 mm; velocity encoding 
parameter (venc) 50–70 cm/s; retrospective gating with 100 reconstructed phases over the cardiac 
cycle). This was used to assess quickly the pulsatility of flow and the approximate time of peak 
arterial flow within the cardiac cycle (using the scanner’s ‘FuncTool’ software), in order to set the 
trigger delay for the subsequent NCE-MRA. If peak flow times varied between the two legs, the used 
setting aimed for the best compromise to aim for flow suppression in both legs if possible. 
Non-contrast-enhanced MRA was acquired using two subtraction-based methods, whose flow-
preparation modules are shown in Fig. 1—the velocity-dependent method VEL-FSD, which for this 
study used an iMSDE module [20] for flow suppression (Fig. 1a) and the acceleration-dependent 
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method ACC-FSD (Fig. 1b). Note that these two flow-suppression modules differ mainly in the signs 
of the motion-sensitization gradients (MSG). 
Each NCE-MRA method used balanced steady-state free precession (bSSFP) for the imaging readout, 
with the following acquisition parameters: TE 1.6 ms, TR 3.5 ms, flip angle 65, acquisition matrix 
256×224×28, FoV 33.3×30.0 cm, slice thickness 2.4 mm, oblique coronal orientation. For each 3D NC-
MRA sequence, scan time was 60 beats per volume, or 300 beats for the 5 volumes acquired. This 
corresponds to 5 minutes at a heart rate of 60bpm. 
 Parallel imaging (regularized ASSET) was used with an acceleration factor of 2. The reconstructed 
resolution was increased by a factor of 2 in all three directions using zero-fill interpolation. Fat-
saturation was applied twice: before the flow-preparation modules, to avoid stripes in the flow-
suppressed image [17]; and before the image readout, to reduce the fat signal in the images. 
For flow-suppression, the ACC-FSD acquisition used an acceleration-preparation module with an 
effective echo time (TEeff) of 50 ms. In addition to a bright-blood image, four dark-artery images 
were acquired using MSG with duration 8 ms and amplitudes 0.5, 1.0, 2.0 and 5.0 mT/m. This results 
in acceleration-encoding parameters (aenc) of 8.96, 4.48, 2.24 and 0.896 m/s2 respectively [19]. For 
both bright- and dark-blood images, the flow-sensitization module was placed at the time of peak 
arterial flow as determined from the phase-contrast measurements, in late systole. Following the 
flow-suppression module, there was a delay of 200ms delay before the readout. This delay was 
added to place the readout in the diastolic portion of the cardiac cycle and thus avoid the reductions 
in vascular image quality that can occur due to rapid inflow into the image volume during the 
readout [18], and its duration was chosen based on typical flow profiles seen in volunteers and 
previous patients during initial testing. For this dataset, the five image volumes were acquired 
consecutively in a single acquisition with automatic adjustment of the MSG amplitudes, and the only 
protocol adjustments needed from the operator were to define the image geometry and the time of 
peak flow.  
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The VEL-FSD acquisition used an iMSDE module with TEeff 30 ms. One bright-blood and four dark-
blood images were collected using MSG with duration 3.4 ms and amplitudes of 0.5, 1.0, 2.0 and 
15.0 mT/m. This corresponded to velocity-encoding parameters (venc) of 23.0, 11.5, 5.76 and 0.768  
cm/s respectively. The final 15.0 mT/m acquisition gave images showing both arteries and veins. For 
the dark-blood images, the  flow-sensitization (iMSDE) module was placed at peak arterial flow, but 
for the bright-blood image a delay of 300 ms was added to place it in diastole. There was no 
additional delay between flow-sensitization module and the readout. As above, the five image 
volumes were acquired consecutively in a single acquisition, with the operator defining only the 
image geometry and the time of peak flow.  
The NCE-MRA acquisitions were followed by our standard clinical CE-MRA protocol using TRICKS, 
with the following scan parameters: TE/TR 2.8/8.3 ms; flip angle 45; FoV 44×30 cm2; acquired 
matrix 512×156×28; slice thickness 2.4 mm. This gives an acquired spatial resolution of 
0.86×1.92×2.40 mm3. The total scan time for a mask phase and 10 dynamic phases was 170 seconds, 
with a temporal resolution of 10.5 seconds and a temporal footprint of 63 seconds. A dose of 10 ml 
Gadobutrol (Gadovist, Schering AG) was given, followed by a 20 ml saline flush, at a rate of 0.5 
ml/second. The orientation, thickness and (approximate) position of the imaging slices were 
matched for the CE- and NCE-sequences. 
Assessment 
To remove the edge regions most commonly affected by signal loss due to magnetic field 
inhomogeneity, the NCE-MRA images were cropped by 30 pixels in the S and I directions, giving a 
final S/I FoV of 29.4 cm.  The CE-MRA images were then cropped in the S and I directions to a 





The images were then assessed independently by two vascular radiologists  with 8 and 4 years 
experience respectively (TCS and APW). For both the CE-MRA and the NCE-MRA datasets, multiple 
phases/image volumes were available for assessment and reviewer was able to choose the ‘best’ 
phase for assessment. Overall 432 segments were evaluated for each of the 3  techniques by each of 
the two reviewers. The reviewers were blinded to patient identity and the examinations were 
reviewed in a semi-randomised order, with care taken to ensure that the datasets for any given 
patient were not assessed in close temporal proximity. For analysis purposes the data from each 
reviewer were treated as separate data-points, given that the purpose of the study was to compare 
the two non-contrast techniques with CE-MRA as the reference standard.  
Both MIPs and individual slices were available for assessment. The below-knee arterial station was 
divided into 9 segments: the proximal and distal below-knee popliteal (Pop), the tibio-peroneal trunk 
(TPT), the proximal and distal anterior tibial (AT), proximal and distal peroneal artery and the 
proximal and distal posterior tibial (PT) arteries. To ensure equivalence between the 2 readers the 
boundary between proximal and distal segments of vessels was defined as the mid point of the 
vessel length assuming it continued to the edge of the field of view (ie. inferiorly for the AT, peroneal 
and PT and superiorly for the popliteal artery).  For each of the 3 techniques, each vessel segment 
was assessed in three separate ways. Firstly the vessel visibility was assessed as either visible (y), not 
visible (n), or partially visible (p). For partially or not visible segments, it was judged whether this 
related to pathology or to the imaging technique. This was left to the discretion of the expert reader 
although as a guide it was suggested that signal loss which either affected the edges of the image, 
with good signal in other arteries, or which affected a wide central region, was deemed as 
“technique related” if no collateral vessels were present to suggest disease. Then, diagnostic 
confidence was assessed on a four-point Likert scale (non-diagnostic, low confidence, moderate 
confidence and high confidence). Finally, the venous contamination was assessed on a three-point 
scale, none (0), some - but not affecting diagnosis (1) and significant - affecting diagnosis (2).   
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Diagnostic confidence was then differentiated into moderate or high confidence versus low 
confidence or non-diagnostic for analysis purposes.  Each segment was also assessed for pathology 
in terms of being normal, stenosis <50%, stenosis>50% or occlusion. From the disease evaluation, 
the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for 
detection of significant stenosis (>50%) were evaluated, considering CE-MRA as the reference 
standard. Non-evaluable segments on NCE-MRA that were visible on TRICKS were counted as 
“misses” for the purposes of evaluating sensitivity.  In order to detect a difference in sensitivity 
between the two tests under consideration, the McNemar Chi-squared test was used.  This was 
calculated on a per-segment, per-limb and per-patient basis. Given the small numbers in the per-




A total of 24 patients  (17 male and 7  female, mean age 64.9 years, range 55–80yrs)  with symptoms 
of peripheral vascular disease were recruited, following referral for routine contrast-enhanced 
peripheral MR angiography.  Of the study group, the majority of patients had claudication 
(Rutherford 1-3), although 2 patients had rest pain (Rutherford 4) and one patient had tissue loss 
(Rutherford 5). The complete breakdown of the claudication patients was 3 with Rutherford 1, 12 
patients with Rutherford 2 and 6 patients with Rutherford type 3 disease. 
Figure 2 shows typical representative images obtained for three example patients using the 3 
different techniques. The phase-contrast velocity profiles are shown for comparison, to demonstrate 
that for each of these cases there is some pulsatility of flow in both legs, even though the flow 
profiles may differ substantially between them. 
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 Figure 3 shows the results for segment visibility out of a possible total of 864 segments for each 
technique. This demonstrates overall better visibility of segments using the VEL-FSD technique as 
compared to the ACC-FSD although neither performed as well as the CE-MRA standard. Of the 256 
segments (out of 864) graded as not visible or partially visible using ACC-FSD, 205 segments (80.0%), 
and of the 157 segments graded as not visible or partially visible using VEL-FSD, 75 segments (47.8%) 
were thought to be due to technique-related issues rather than due to occlusive pathology. 
Concordance between the two reviewers regarding whether a segment was not visible due to 
technique or pathology was 50% for the ACC-FSD, 36.2% for VEL-FSD and 55.6% for CE-MRA. 
Overall diagnostic confidence was rated as moderate or high in 98.5% of segments scored using CE-
MRA, 79.9% using ACC-FSD and 92.1% using VEL-FSD. Table 1 shows the diagnostic confidence of 
each method by segment. The sensitivity, specificity, PPV and NPV of the two methods using CE-
MRA as the gold standard and considering stenosis >50% as significant disease on a per segment, per 
limb and per patient basis is shown in Table 2. McNemar’s Chi-squared test did not demonstrate 
significant difference in sensitivity for significant stenosis  between the two techniques on a per-
segment (p=1.00), per-limb (p=0.13) or per-patient (p=0.77) basis, although the per limb results 
came closest to reaching significance.  
The degree of venous contamination (Figure  4) was scored as none in 96% of evaluated segments 
using CE-MRA as compared to 85.8% using ACC-FSD and 72.2% using VEL-FSD. The respective 
percentage scores for some venous contamination were 3.5%, 11.9% and 23.3% and for significant 
venous contamination 0.5%, 2.3% and 4.5%.  
It was noted that in four cases, the phase contrast flow profiles showed little or no flow pulsatility 
for one of the legs, and that this corresponded with a poor signal in acceleration-sensitized NCE-





The aim of this study was to explore the use of novel non-contrast MRA techniques for the 
evaluation of the infregeniculate vessels in patients with PAD. The infrageniculate arteries pose a 
challenging imaging problem by conventional imaging modalities due to the small size of the vessels 
and the presence of calcification hampering assessment by CTA and DUS. Nevertheless, as 
techniques both by open surgery and in particular by endovascular means improve, stenoses and 
occlusions in these vessels that were once untreatable are now being routinely revascularised. The 
emergence of the angiosome concept in targeting revascularisation [21] means accurate pre-
procedure imaging is key in planning intervention. Better MRA reconstruction algorithms recently 
have led to an improvement in spatial resolution and quality [22,23] In addition, a number of NCE-
MRA techniques have also been described of which some are flow-independent [24] and others rely 
on the inherent properties of flowing blood [25-27]. Most of these studies have demonstrated 
technical feasibility although real-world data in specific at-risk population groups such as diabetic 
patients remains limited [28].  Newer developments such as examinations performed at 3T hold 
promise for the future [29,30]. 
This work assessed two recently-developed flow-dependent subtraction-based methods of 
performing NCE-MRA: the VEL-FSD technique, which has previously been demonstrated [15] to 
provide visibility of the infrageniculate vessels in patients with PAD, relies on the velocity of blood; 
and ACC-FSD, which relies on acceleration and has been shown to provide beneficial artery-vein 
separation in healthy controls [16]. This study compares the two methods when used for assessment 
of the infrageniculate vessels, with CE-MRA as a reference standard. We have demonstrated that 
overall visualisation of the various infrageniculate segments is reasonable with both techniques 
when compared to CE-MRA. The experienced reporters felt more comfortable in terms of diagnostic 
confidence using VEL-FSD rather than ACC-FSD. Overall per-patient sensitivity to disease is high for 
both techniques, although the per-segment sensitivity is considerably lower. This is not entirely 
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unsurprising given that multifocal disease is common in this patient cohort  Another contributory 
factor could be  related to technique failure near the edge of the field of view although previously 
similar reported issues with vessel visualisation are less evident with the current version of the VEL-
FSD method.As expected the ACC-FSD technique is more resistant to venous contamination than 
VEL-FSD. 
Examination of the flow profiles measured by phase contrast MR helps us to better understand 
some of the strengths and weaknesses of these flow-dependent NCE-MRA techniques. These 
profiles were used to align the timing of the flow-suppression modules with peak arterial flow. 
However in some cases the flow profiles for the two legs differed substantially and it was not 
possible to find a delay time which was optimal for both legs simultaneously and in these situations 
the chosen timings aimed to allow flow suppression in both legs as far as possible. Future work 
might improve this by performing either the flow-sensitization or the entire imaging process for the 
two legs separately in such cases, so that each leg could be optimised independently. 
In many cases, the flow profiles measured in the below-knee arteries were adversely affected by 
proximal disease in the above-knee vessels. Flow velocities were typically much lower than those 
seen in healthy volunteers. The flow profiles also revealed that in some cases, there was little or no 
flow acceleration in legs with severe upstream stenoses. In such cases, the vessels were poorly 
depicted by the ACC-FSD sequence. Thus, ACC-FSD is probably unsuitable for reliable clinical imaging 
in such cases. However, ACC-FSD may still have other beneficial uses: it is useful in mapping normal 
anatomy without venous contamination, and in some clinical situations  it may be a useful addition 
to VEL-FSD to aid the discrimination of arteries and veins, which are not always separated by this 
technique. Since both VEL-FSD and ACC-FSD may be acquired using the same bright-blood images, a 




Both NCE-MRA methods used bSSFP as the readout method. The sensitivity of this method to off-
resonance effects does limit its success in the lower extremities, especially given the relatively poor 
homogeneity of the main magnetic field often achieved in this region. Such off-resonance effects 
limit the useful maximum FoV of the method, which may account for the lower performance of 
these methods compared to CE-MRA. In future, it is hoped that alternative readout strategies will 
improve the underlying image quality and thus improve diagnostic performance. 
Other limitations of the study include the relatively small number of patients studied although it is 
anticipated that as the techniques become more refined, in the future larger patient populations 
with specific at-risk subgroups such as diabetic patients will be studied.  Both techniques described 
rely on assessment of flow in the popliteal and infrageniculate vessels, however only the 
infrageniculate vessels have been investigated here.  
Ultimately, it may be the case that conventional imaging techniques (such as ultrasound or CT) may 
be employed for imaging of the larger ilio-femoral vessels with single-station below-knee NCE-MRA 
employed in situations where conventional techniques may not be optimal, for instance in the obese 
patient or in those with calcified vessles.. The infrageniculate region was chosen for analysis with the 
expectation that even better results would be achieved in the iliac or femoro-popliteal segments due 
to the larger size of the vessels. Another role for this techanique could be in patients with mixed 
arterial and venous leg ulcers where rapid arterio-venous shunting can limit the use of CE-MRA due 
to venous contamination. Potentially an algorithm whereby CE-MRA is employed in the supra-
inguinal and femero-popliteal segments with NCE-MRA techniques below the knee could be 
considered. 
Finally, CE-MRA has been used as the reference standard in line with most published studies in the 
literature [31]. It may be that digital subtraction angiography (DSA) is a more appropriate “gold 
standard” to compare with although clearly there may be practical and ethical issues in performing 
such a comparison. 
15 
 
Flow-dependent NCE-MRA techniques using acceleration and velocity flow sensitization may have 
diagnostic value in the assessment of patients with peripheral arterial disease. In this study 
comparing the initial diagnostic performance in such patients using both techniques, there was 
greater diagnostic confidence using the velocity sensitization approach (VEL-FSD) but at the expense 
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Fig. 1: flow-preparation modules for (a) velocity sensitization and (b) acceleration sensitization. The 





Fig. 2: Typical examples of velocity-dependent, acceleration-dependent, and contrast-enhanced 
MRA, images for three patients. The corresponding phase-contrast velocity profiles demonstrate 
flow is pulsatile in both legs, despite some differences between them.  
 
 
Fig.3: Segment visibility rating for each of the 3 techniques (864 segments in total for each technique 












Fig. 5: Example images from cases with little acceleration in one leg, and poor acceleration-sensitized 
NCE-MRA from the corresponding leg. Velocity-dependent, acceleration-dependent, and contrast-
enhanced MRA images are shown, with the phase-contrast velocity profiles demonstrating the lack 























CE-MRA 99 99 99 99 99 98 98 98 98 
ACC-FSD 47.9 63.5 81.3 86.5 86.5 87.5 87.5 87.5 86.5 




Table 1: Percentage of segments with diagnostic confidence rated as moderate or high for each 
method by anatomical location (Proximal popliteal, Distal popliteal, Tibioperoneal trunk, Proximal 
anterior tibial, Distal anterior tibial, Proximal peroneal, Distal peroneal, Proximal posterior tibial, 










Table 2: Calculated sensitivity and specificity of the two methods for significant disease (PPV - 









ACC-FSD: per-segment 63.4 92.5 50.4 95.4 
VEL-FSD: per-segment 65.3 92.7 52.5 95.6 
ACC-FSD: per-limb 73 66.1 57.4 79.6 
VEL-FSD: per-limb 87.2 61.4 60.7 87.5 
ACC-FSD: per-patient 92 60.9 71.9 87.5 
VEL-FSD: per-patient 96 43.5 64.9 90.9 
 
